Global Markets Comment
We see IAG as the leading network operator in Europe and its cost reduction programme have largely panned out in their favor. Despite the low visibility on when travel restrictions will be relaxed, we believe that the UK’s lead in approving a COVID-19 vaccine will eventually lead to the establishment of travel corridors and the remobilization of aviation. We also expect IAG to reach cash break even during 1H21 and has over €9bn of liquidity to see it through summer 2021. Share price have recently broke out of the 200-day moving average and we see further upside in IAG as it is still down 35% YTD despite positive vaccine news.
Performance since inception*
IAG, also known as International Airlines Group, is one of the world’s largest airline groups with 598 aircrafts and is the result of a merger between British Airways and Iberia, the flag carriers of UK and Spain. It also acts as the holding company comprising UK-based airline Brish Airways, Spanish-based Iberia and Vueling, and Irish-based Aer Lingus
Price History 1 year
IAG has embarked on an extensive cost reduction programme, which includes retring older fleet, material redundancies/improved productivity terms and more efficient procurement from suppliers. IAG is expected to be the largest contributor towards both long and short haul capacity in Europe for 1Q21 and we see IAG as the leading network operator in the region. With uncertainty around Brexit likely resolved, we believe IAG’s can likely re-rate and ride on the wave of recovery following a vaccine
Price History 5 years
Risk in Investment Case
Main risk factors for International Airlines Group are 1) Slower than expected recovery of global aviation traffic; 2) Higher than expected cash burn rate which may result in worsening liquidity position and further fundraising.
- Confirm that I meet the requirements to qualify as:
- a "Professional Investor” in accordance with Section 1 of Part 1 of Schedule 1 of the Securities and Futures Ordinance (Cap 571 of the Law of Hong Kong) and as a “Private Banking Customer” as defined in the circular issued by the Hong Kong Monetary Authority on 12 June 2012; and/ or
- an "accredited investor" or "institutional investor" as defined in the Securities and Futures Act (Chapter 289) of Singapore
Content provided on “as is” and “as available” basis
- Confirm my understanding that the materials, information or reports published, distributed or otherwise made available on the UBS Website
(a) are published for information purposes only and are subject to change at any time without notice;
(b) have been created without any regard to the specific investment objectives, financial situation or particular needs of any specific recipient and should not be construed as a solicitation, offer or recommendation or advice to buy or sell any securities, investment or other financial instruments, to effect any transactions or to conclude any legal act of any kind whatsoever.